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Dermatitis as a component of the fetal inﬂammatory response syndrome is associated
with activation of Toll-like receptors in epidermal keratinocytes
Aims: Microbial invasion of the amniotic cavity (MIAC)
elicits a fetal inﬂammatory response such as funisitis
and chorionic vasculitis. However, little is known about
the changes of fetal skin during MIAC. Toll-like
receptors recognize microbial products and initiate
an immune response. The aims of this study were to
examine histopathological features of fetal skin exposed
to MIAC and to assess the changes in Toll-like receptor
(TLR)-2 and TLR-4 expression.
Methods and results: Skin samples were obtained from
fetal autopsies (n ¼ 12). The cases were classiﬁed
according to the presence (n ¼ 8) or absence (n ¼ 4)
of acute chorioamnionitis and analysed by immuno-
histochemistry using a panel of antibodies. Leucocytic
inﬁltrates into the superﬁcial dermis were observed in
cases with chorioamnionitis; the majority of inﬂamma-
tory cells were neutrophils, lymphocytes and histio-
cytes. TLR-2 immunoreactivity in the skin was
stronger in fetuses with chorioamnionitis than in those
without this condition. However, immunoreactivity
of TLR-4 in the fetal skin was constitutively expres-
sed, regardless of the presence or absence of chorio-
amnionitis.
Conclusions: This study demonstrates for the ﬁrst time
that fetal dermatitis can be detected and is part of
the fetal inﬂammatory response syndrome (FIRS). We
propose that this ‘FIRS-associated fetal dermatitis’ is a
fetal counterpart of chorioamnionitis.
Keywords: chorioamnionitis, dermatitis, fetal dermatitis, fetal inﬂammatory response syndrome, fetal skin,
keratinocytes, Toll-like receptors
Abbreviations: FIRS, fetal inﬂammatory response syndrome; HBD, human b-defensins; IL, interleukin;
MIAC, microbial invasion of the amniotic cavity; TLR, Toll-like receptor; TNF, tumour necrosis factor
Introduction
Microbial invasion of the amniotic cavity (MIAC)
generates a unique environment for the propagation
of infection and inﬂammation in both the mother and
fetus. Fetal and maternal inﬂammatory responses are
closely linked to preterm labour and delivery and have
been associated with increased perinatal morbidity
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enterocolitis, periventricular leukomalacia) and the
long-term sequelae such as cerebral palsy and chronic
lung disease.
1–4
During the course of MIAC, the fetus is bathed in
infected amniotic ﬂuid, with evidence of an inﬂamma-
tory response easily demonstrated by elevated amniotic
ﬂuid white blood cell count,
5 as well as levels of
proinﬂammatory cytokines in fetal plasma and amni-
otic ﬂuid.
6–8 We have previously designated the com-
plex cascade of clinicopathological events which
increase neonatal morbidity and elevate fetal plasma
interleukin (IL)-6 over 11 pg ⁄ ml as the fetal inﬂam-
matory response syndrome (FIRS).
8 Since amniotic
epithelial cells would be in direct contact with infected
amniotic ﬂuid, histological chorioamnionitis is a hall-
mark of a tissue reaction frequently associated with
MIAC.
9
Toll-like receptors (TLRs) are essential components of
the innate immune system implicated in recognizing
of the presence of microorganisms. So far, 11 TLRs
have been identiﬁed in mammals and each TLR binds
with speciﬁc ligands.
9 TLR-2 predominantly recognizes
Gram-positive bacterial components, such as peptido-
glycans and the products of Mycoplasma and fungi,
while TLR-4 recognizes bacterial endotoxin, which
is a component of the cell wall of Gram-negative
bacteria.
10–12 A previous study demonstrated the
over-expression of both TLR-2 and TLR-4 in the chorio-
amniotic membranes of patients with infection- and
non-infection-related conditions associated with preg-
nancy,
13 as is the case with other types of surface
epithelia of the body, such as the intestine
14 and
tracheobronchial tree.
15 Expression of TLR-2 and
TLR-4, along with activation ofNF-jB, was signiﬁcantly
higher in preterm deliveries with chorioamnionitis,
13
indicating that engagement of the innate immune
system is occurring during normal spontaneous labour
as well as during overt inﬂammatory states.
Human skin, positioned at the interface between the
internal milieu and external environment, is endowed
with innate immune defence mechanisms against infec-
tion.
16 The epidermis, formed of stratiﬁed keratinocytes,
is the ﬁrst line of defence against microbial pathogens.
The skin epidermis is not only a mechanical barrier, but
also an active immune organ that participates in the
protection of the host against microbial invasion by
killing pathogenic microorganisms through the produc-
tion of cationic antimicrobial peptides such as human
b-defensins (HBD) and cathelicidin.
17,18 Epidermal ker-
atinocytes also express TLRs, and the expression of
TLR-2 and TLR-4 mRNA and proteins has been demon-
strated in human keratinocytes along with accessory
signalling molecules.
19,20 Microbial killing in the epider-
mismaybeperformedbyepidermalkeratinocytesandby
neutrophils attracted to the site of infection by keratino-
cyte-derived chemokines following TLR activation.
21
Constant contact with microorganisms in cases of
MIAC would explain the signiﬁcant inﬂammatory
response observed in fetal membranes. While histo-
logical chorioamnionitis is a well-deﬁned pathological
entity with demonstrated clinical signiﬁcance on the
perinatal outcome,
6,22 little is known about the
inﬂammatory reaction of fetal skin in MIAC. We
postulated that MIAC could generate a fetal skin
immune response, which is initiated by the recognition
of microorganisms by keratinocytes. The purpose of our
study was to determine if the fetal skin develops an
inﬂammatory response (dermatitis) and evaluate whe-
ther the expression of TLR-2 and TLR-4 is altered
in cases of histological chorioamnionitis. This was
achieved through the analysis of fetal skin from
perinatal autopsy cases.
Materials and methods
tissue samples
Fetalabdominalskinwasobtainedfromfetuseswhodied
shortly after delivery due to immaturity (21–24 weeks’
of gestation). All of the cases died within 8 h after birth.
The study groups consisted of fetuses born to mothers
without (n ¼ 4) and with (n ¼ 8) histological chorio-
amnionitis. The diagnosis of histological chorioamnio-
nitis was made as previously described.
8 All patients’
parents provided written informed consent prior to
sample collection. The utilization of tissue for research
wasapprovedbytheInstitutionalReviewBoards ofboth
Wayne State University and the National Institute of
Child Health and Human Development.
immunohistochemistry
TLR-2, TLR-4, CD15, CD45 and CD68 expression was
examined by immunohistochemistry. Fetal skin sam-
pleswereﬁxedwith10%bufferedformalinfor24 hprior
to parafﬁn embedding for routine histological examina-
tion and immunohistochemistry. Serial sections (5 lm
thick) were obtained from each case. Deparafﬁnization,
rehydration, antigen retrieval and immunostaining
were performed using an automatic immunostainer
(Ventana Discovery; Ventana Medical Systems, Inc.,
Tucson, AZ, USA). The sections were treated with 10%
normal horse serum for 20 min. The primary antibodies
employed were polyclonal goat anti-TLR-2 and -TLR-4
(1 : 50 and 1 : 60, respectively; Santa Cruz Biotechno-
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mouse anti-CD15 (Dako, Carpinteria, CA, USA), and
CD45 (Ventana Medical Systems) and CD68 (Dako).
Sections were incubated with biotin-conjugated horse
anti-goat (1 : 400; Vector Laboratories, Inc., Burlin-
game, CA, USA) or biotinylated horse anti-mouse
IgG (Universal Vector kit; Vector Laboratories) as a
secondary antibody. A diaminobenzidine MAP kit
(Ventana Medical Systems) was used for chromogen
reaction and counterstaining was performed with
Mayer’s haematoxylin. Primary antibodies were
quenched with excessive amounts of corresponding
blocking peptides (Santa Cruz Biotechnology) and
used as negative controls. Immunoreactivity for TLR-2,
TLR-4, CD15, CD45 and CD68 was evaluated semi-
quantitatively and graded as 0 (negative or low num-
bers of positive cells), 1 (focal scattered immunoreactive
cells) and 2 (diffuse and intense inﬁltration of positive
cells) from 5 high-power ﬁelds (·400).
immunofluorescence
Snap-frozen sections in OCT compound of fetal skin
born to mothers without (n ¼ 3) and with (n ¼ 7)
histological chorioamnionitis were used for immuno-
ﬂuorescence for TLR-2, TLR-4, CD3, IL-1a, tumour
necrosis factor (TNF)-a, IL-8 and HBDs 1–3. The
antibodies used were polyclonal goat anti-TLR-2, anti-
TLR-4, anti-HBD-1, anti-HBD-2 and anti-HBD-3 (either
1 : 50 or 1 : 100; Santa Cruz Biotechnology), mono-
clonal mouse anti-CD3 (1 : 50; Novocastra, Newcastle
upon Tyne, UK), anti-IL-1a (1 : 50; eBioscience, San
Diego, CA, USA), anti-IL-8 (1 : 50; Abcam Inc., Cam-
bridge, UK) and polyclonal rabbit anti-TNF-a (1 : 50;
Santa Cruz Biotechnology). Brieﬂy, the slides were
incubated with a serum-free protein blocking solution
(Dako) for 20 min at room temperature and incubated
with primary antibodies either for 2 h at room tem-
perature or overnight at 4 C. Subsequently, secondary
antibodies, FITC-conjugated horse antimouse (Vector
Laboratories), donkey anti-goat antibody or donkey
anti-rabbit antibody (Biomeda, Foster City, CA, USA)
were applied at 1 : 200 dilution for 1 h.
statistical analysis
The results are presented as proportions of each
grading score according to the study groups and
Fisher’s exact test was used for comparisons. A P-value
of <0.05 was considered signiﬁcant.
Table 1. Clinicopathological proﬁles of the perinatal autopsies
Case Sex
Gestational
age at delivery
(weeks + days)
Birth
weight
(g)
Clinical
diagnosis
Histological
chorioamnionitis
(CV ⁄ F)
AF
culture
Survival
(h)
1 F 22 + 5 500 pPROM – (– ⁄ –) ND 1
2 M 22 280 Preeclampsia – (– ⁄ –) ND 0
3 F 23 500 PTL – (– ⁄ –) ND 1.5
4 M 22 + 1 410 PTL – (– ⁄ –) ND 2
5* M 23 + 2 540 PTL + (+ ⁄ –) – 7.5
6* F 21 + 3 400 PTL + (+ ⁄ +) Ureaplasma 0
7* M 21 + 6 360 PTL + (+ ⁄ +) – 3
8* M 23 + 2 620 PTL + (+ ⁄ –) – 1.5
9* F 23 + 4 600 pPROM + (+ ⁄ +) ND 1.5
10* M 22 520 pPROM + (+ ⁄ +) – 0
11* M 22 + 1 530 PTL + (+ ⁄ +) Candida 2.5
12* M 22 + 5 600 pPROM + (+ ⁄ +) – 1.5
*The cases with fetal dermatitis.
pPROM, Preterm premature rupture of membranes; PTL, preterm labour with intact membranes; CV, chorionic vasculitis;
F, funisitis; AF, amniotic ﬂuid; ND, not done.
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microscopic findings
Clinicopathological characteristics of the cases are
summarized in Table 1. All eight cases with histo-
logical chorioamnionitis had fetal vasculitis (acute
chorionic vasculitis and ⁄ or funisitis). Six of these cases
had both chorionic vasculitis and funisitis, while two
cases had only chorionic vasculitis. Fetal skin samples
from the autopsy cases that had histological chorioam-
nionitis invariably showed perivascular inﬂammatory
cell inﬁltration in the superﬁcial dermis. The degree of
inﬂammation in fetal skin was less intense than that of
the chorioamniotic membranes in individual cases. The
inﬂammatory cells were readily recognized by CD15,
CD45 and CD68 immunoreactivity. Dermoepidermal
junctions were frequently studded with inﬂammatory
cells and migrating neutrophils were occasionally
found in the epidermis (Figure 1A,C). Immunohisto-
chemical analysis showed that the inﬂammatory inﬁl-
trates were composed mainly of CD15+ neutrophils,
CD3+ T lymphocytes and CD68+ histiocytes. The fetal
skin from pregnancies with histological chorioamnio-
nitis showed greater inﬁltration of CD15+ and CD68+
cells than those from pregnancies without histological
chorioamnionitis (Figure 1B,D; Table 2). A similar
observation was made in the mean rate of CD45+
cells, yet the difference did not reach statistical signi-
ﬁcance (Table 2).
expression of tlr-2 and tlr-4
The fetal skin expressed TLR-2 and TLR-4 in the
epidermis regardless of histological chorioamnioni-
tis status. However, the expression of TLR-2 was
CD15
H&E
Histologic chorioamnionitis (–) Histologic chorioamnionitis (+)
A
CD
B
Figure 1. Histological features of abdominal skin obtained from perinatal autopsy cases with and without histological chorioamnionitis.
Epidermis and dermis do not show signiﬁcant changes in a fetus without histological chorioamnionitis (A,C). An inﬂammatory inﬁltrate is
evident in the epidermis and dermis of a fetus with histological chorioamnionitis (B,D). The dermoepidermal junction is studded with CD15+
neutrophils.
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histological chorioamnionitis than in those without
this condition (Figure 2A,B; Table 2). Signiﬁcant TLR-2
immunoreactivity was found only in the keratinocytes
in the superﬁcial layer of the epidermis in cases without
histological chorioamnionitis (Figure 2A). In contrast,
Table 2. Proportions of each grading score of expression of CD15, CD68, CD45, TLR-2, and TLR-4 in the fetal skin
Fetal skin without chorioamnionitis (n ¼ 4) Fetal skin with chorioamnionitis (n ¼ 8)
P-value Grade 0 Grade 1 Grade 2 Grade 0 Grade 1 Grade 2
CD15 75% (3 ⁄ 4) 25% (1 ⁄ 4) 0% (0 ⁄ 4) 0% (0 ⁄ 8) 62.5% (5 ⁄ 8) 37.5% (3 ⁄ 8) 0.013*
CD68 75% (3 ⁄ 4) 25% (1 ⁄ 4) 0% (0 ⁄ 4) 12.5% (1 ⁄ 8) 25% (2 ⁄ 8) 62.5% (5 ⁄ 8) 0.023*
CD45 0% (0 ⁄ 4) 75% (3 ⁄ 4) 25% (1 ⁄ 4) 0% (0 ⁄ 8) 25% (2 ⁄ 8) 75% (6 ⁄ 8) > 0.05
TLR-2 75% (3 ⁄ 4) 25% (1 ⁄ 4) 0% (0 ⁄ 4) 0% (0 ⁄ 8) 62.5% (5 ⁄ 8) 37.5% (3 ⁄ 8) 0.013*
TLR-4 0% (0 ⁄ 4) 100% (4 ⁄ 4) 0% (0 ⁄ 4) 0% (0 ⁄ 8) 100% (8 ⁄ 8) 0% (0 ⁄ 8) > 0.05
*P < 0.05, signiﬁcantly different.
TLR-4
TLR-2
Histologic chorioamnionitis (–) Histologic chorioamnionitis (+)
A
CD
B
Figure 2. Expression proﬁles of TLR-2 and TLR-4 in the fetal skin with and without histological chorioamnionitis. In cases without histological
chorioamnionitis, faint TLR-2 immunoreactivity (A) is found only in the superﬁcial layer of the epidermis, while TLR-4 immunoreactivity (C)
is found throughout the whole layer of the epidermis. However, both TLR-2 (B) and TLR-4 (D) are expressed throughout the whole epidermis
in cases with histological chorioamnionitis. The increase in TLR-4 immunoreactivity is not as prominent as that of TLR-2. Insets show
immunoﬂuorescence staining results with corresponding antibodies.
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through to the superﬁcial layers were strongly immuno-
positive for TLR-2 in fetuses with histological chorio-
amnionitis (Figure 2B). TLR-2 immunoreactivity was
also readily detected in dermal capillary endothelial
cells and hair follicles. TLR-4 immunoreactivity in the
keratinocytes was constitutive and diffuse through-
out the whole layer of epidermis regardless of whether
or not histological chorioamnionitis was present
(Figure 2C,D; Table 2). Cases with histological chorio-
amnionitis also showed a marked increase in the
expression of proinﬂammatory cytokines (IL-1a,T N F - a)
and chemokine IL-8 (Figure 3). Increases in IL-8
immunoﬂuorescence were especially prominent and
were observed throughout the whole thickness of the
epidermis. Among the HBDs, HBD-1 immunoreactivity
was observed throughout the entire epidermis of cases
both with and without histological chorioamnionitis.
In contrast, HBD-2 and HBD-3 were expressed only
by keratinocytes in the superﬁcial epidermis in cases
without histological chorioamnionitis, while distinct
immunoreactivity was found throughout the epider-
mis in the cases with histological chorioamnionitis
(Figure 4).
Discussion
We have shown that fetal dermatitis is present in cases
of histological chorioamnionitis. This in utero process
observed in mid-trimester pregnancies is associated
with increased expression of TLR-2 and TLR-4 and
concomitant up-regulation of cytokines ⁄ chemokines
and antimicrobial factors in epidermal keratinocytes.
Our observations suggest that fetal keratinocytes are
actively involved in the fetal inﬂammatory response
and demonstrate that a unique pathological entity
(fetal dermatitis) can occur in histological chorio-
amnionitis.
Funisitis and chorionic vasculitis are the histological
counterparts of FIRS in that these processes represent
fetal vasculitis and show a strong correlation with fetal
plasma IL-6 levels.
8 However, in terms of anatomical
Histologic chorioamnionitis (–) Histologic chorioamnionitis (+)
IL-1α
TNFα
IL-8
Figure 3. Expression of proinﬂammatory cytokines [interleukin (IL)-1a, tumour necrosis factor (TNF)-a] and chemokine (IL-8) in the fetal skin.
Expression of IL-1a, TNF-a and IL-8 is markedly increased in the fetal epidermis of a case with histological chorioamnionitis, compared with that
of a case without this condition.
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inﬂammation. We believe that the fetal skin represents
a primary physiological barrier capable of responding
to the presence of microbial factors and protecting
against MIAC. Our ﬁndings further support our hypo-
thesis that this process is of the utmost signiﬁcance as a
response to MIAC, since it represents a purely intrafetal
inﬂammatory response (although the number of cases
in the present study was not sufﬁcient to assess its
relationship with FIRS).
The gold standard for the diagnosis of MIAC is a
positive amniotic ﬂuid culture for bacteria or genital
Mycoplasmas.
23 Microorganisms (Candida species and
Ureaplasma urealyticum) were demonstrated in only
2 out of 7 cases with chorioamnionitis in which
amniotic ﬂuid cultures were performed, making
it difﬁcult to deﬁne cases complicated by MIAC
through cultures alone. However, the presence of
chorionic vasculitis and ⁄ or funisitis represents evi-
dence for the existence of MIAC. It is noteworthy
that standard clinical microbiological culture has
limitations and is not sensitive enough to detect all
cases of MIAC. For example, amniotic ﬂuid cultures
missed 40% of patients with microbial invasion by
U. urealyticum as determined by polymerase chain
reaction in cases with preterm premature rupture of
membranes.
24
Expression of TLR-2 and TLR-4 was dependent upon
the differentiation status of human keratinocyte cell
line (HaCaT). It seems logical that there should be a
gradient of TLRs in the epidermis since pathogens are
present in the upper, more differentiated layers.
25 We
found a gradient of TLR-2 in fetal epidermis that was
not exposed to MIAC. In cases with histological chor-
ioamnionitis, however, signiﬁcant TLR-2 expression
was found in all the epidermal layers. Lipopolysaccha-
ride and interferon-c treatment of human keratinocytes
in vitro increases the expression of TLR-2 50-fold, and
TLR-4 5-fold.
21 The relatively marked up-regulation of
TLR-2 in the fetal epidermis compared with TLR-4
in our study is consistent with this in vitro observa-
tion. Expression patterns of TLR-2 seem to be more
Histologic chorioamnionitis (–) Histologic chorioamnionitis (+)
HBD-1
HBD-2
HBD-3
Figure 4. Expression of antimicrobial peptide human b-defensins (HBD)-1, HBD-2 and HBD-3 in fetal skin. Increases in HBD-2 and HBD-3
expression are more prominent in a case affected with histological chorioamnionitis, compared with a case without this condition. HBD-2 and
HBD-3 expression seems to be more inducible in nature.
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constitutive in human keratinocytes. Although their
expression patterns seem to differ slightly, there is
emerging evidence of cross-talk between TLR-4 and
TLR-2. TLR-4 activation by lipopolysaccharide up-
regulates the expression of TLR-2 in endothelial cells.
26
The changes in TLR-2 and TLR-4 expression are
basically identical to those of the fetal membranes
affected with histological chorioamnionitis.
13 Func-
tionally competent activation of the TLR signalling
pathway is shown through associated changes in
proinﬂammatory cytokines and the chemokine IL-8.
The histopathological intensity of dermatitis in fetal
skin was much less severe compared with that of
chorioamnionitis in the chorioamniotic membranes.
This may be related to the relative immunological
immaturity of the fetus. Even in placental inﬂammation,
fetal membranitis, whose inﬂammatory inﬁltrates are
of maternal origin, almost inevitably precedes chori-
onic vasculitis or funisitis, which represents fetal vascu-
litis.
27 Characterization of the immunophenotype of the
inﬂammatory cells revealed mixed-type inﬁltrates com-
posed of neutrophils, lymphocytes and histiocytes, sug-
gesting chronicity of the inﬂammatory process. Among
the generalized activation of immune mechanisms,
prominent up-regulation of IL-8 by keratinocytes is
noteworthy.
21 This ﬁnding strongly implies that fetal
epidermal keratinocytes contribute in a signiﬁcant way
to the increase of IL-8 in amniotic ﬂuid, which then
enhances neutrophilic migration into the amniotic
cavity.
21,28 The neutrophils in intra-amniotic inﬂam-
mation are fetal in origin.
29 The presence of migrating
neutrophils in fetal epidermis, along with strong IL-8
expression by keratinocytes, suggests that the fetal skin
can also be a signiﬁcant transmigratory route for fetal
neutrophils, along with chorionic plate vessels and the
umbilicalcord,whichwehaveproposedaspotentialsites
of origin of amniotic ﬂuid neutrophils.
30 In this context,
cases with increased amniotic ﬂuid white blood cell
counts in the absence of histological chorioamnionitis
may be potential candidates for transmigration of fetal
leucocytes across the skin.
In summary, we report for the ﬁrst time that fetal
dermatitis is a distinct and unique pathological entity
associated with MIAC, and probably represents an
early stage of FIRS. We deﬁne the condition as ‘FIRS-
associated fetal dermatitis’, as it is the fetal counterpart
of placental histological chorioamnionitis and shares a
common pathogenesis. The study also clearly shows
that fetal skin, even in the mid trimester, is capable of
recognizing microbial products through pattern recog-
nition receptors TLR-2 and TLR-4 and, thus may
actively participate in innate immune defence. Recent
reports on early postnatal skin colour changes in term
newborns with subclinical histological chorioamnioni-
tis also provide interesting evidence that biological
alterations in fetal skin are occurring in association
with chorioamnionitis.
31 Finally, the ﬁndings of our
study also emphasize the signiﬁcance of meticulous
examination of the fetal skin during routine perinatal
autopsies.
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